Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial

Kelly, K.; Patel, M.; Infante, J.R.; Iannotti, N.; Nikolinakos, P.; Leach, J.; Wang, D.; Chandler, J.; JERUSALEM, Guy; Gurtler, J.; Arkenau, H-T.; Bajars, M.; von Heydebreck, A.; Speit, I.; Heery, Ch.; Gulley, J.L.

Request a copy

Unpublished conference/Abstract (Scientific congresses and symposiums)

Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial

Kelly, K.; Patel, M.; Infante, J.R. et al.

2016 • American Association for Cancer Research Annual Meeting

Permalink
https://hdl.handle.net/2268/199890

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Safety of Avelumab (MSB0010718C), an anti-PD-L1 antibody ... abstract.pdf

Publisher postprint (602.06 kB)

Request a copy

Annexes

Safety of Avelumab (MSB0010718C), an anti-PD-L1 antibody ... dias.pdf

Publisher postprint (343.7 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology

Disciplines :

Oncology

Author, co-author :

Kelly, K.

Patel, M.

Infante, J.R.

Iannotti, N.

Nikolinakos, P.

Leach, J.

Wang, D.

Chandler, J.

JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Service d'oncologie médicale

Gurtler, J.

More authors (6 more)

Language :

English

Title :

Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial

Publication date :

April 2016

Event name :

American Association for Cancer Research Annual Meeting

Event place :

New Orleans, United States

Event date :

April 16-20, 2016

Audience :

International

References of the abstract :

CT132

Available on ORBi :

since 07 July 2016

Statistics

Number of views

59 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics